LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25

LIFECORE BIOMEDICAL, INC. DE

Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Aug 5, 2026

$6.39+0.01 (+0.16%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

LIFECORE BIOMEDICAL, INC. DE balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-05-25	FY 2024 2024-05-26	FY 2023 2023-05-28	FY 2022 2022-05-29	FY 2021 2021-05-30	FY 2020 2020-05-31	FY 2019 2019-05-26	FY 2018 2018-05-27	FY 2017 2017-05-28	FY 2016 2016-05-29	FY 2015 2015-05-31	FY 2014 2014-05-25	FY 2013 2013-05-26	FY 2012 2012-05-27	FY 2011 2011-05-29	FY 2010 2010-05-30	FY 2009 2009-05-31
Cash & Equivalents	8.27	8.46	19	1.64	1.30	0.55	1.47	3.22	5.73	9.97	14	14	14	22	8.14	28	43
Short-Term Investments	–	–	–	–	–	–	–	–	–	–	–	–	1.55	–	28	–	–
Cash & Short-Term Investments	8.27	8.46	19	1.64	1.30	0.55	1.47	3.22	5.73	9.97	14	14	15	22	36	28	43
Receivables	–	31	29	38	32	76	70	54	46	46	46	44	36	32	22	–	–
Inventory	32	40	41	36	34	66	54	32	24	26	25	25	24	22	20	–	–
Prepaid Expenses & Other	1.45	1.44	4.92	2.05	1.50	14	8.26	7.96	3.50	4.47	5.46	3.17	2.86	2.58	5.99	–	–
Total Current Assets	86	81	94	117	145	157	133	97	81	86	93	91	86	81	86	–	–
Property, Plant & Equipment	129	149	134	119	107	192	200	160	133	121	84	74	66	63	52	–	–
Gross Property, Plant & Equipment	186	199	191	166	145	287	280	229	194	175	135	119	105	97	–	–	–
Accumulated Depreciation	-57	-50	-57	-47	-38	-95	-80	-69	-60	-54	-50	45	-39	-34	–	–	–
Operating Lease Right-of-Use Assets	–	2.44	4.28	5.55	14	25	0	–	–	–	–	–	–	–	–	–	–
Goodwill	14	14	14	14	14	34	77	55	55	50	50	50	50	50	36	41	–
Intangible Assets	4.20	4.20	4.20	1.08	8.04	13	15	22	23	21	56	57	58	59	16	16	–
Other Long-Term Assets	11	9.88	2.92	2.89	3.42	2.16	2.93	5.16	2.92	1.75	1.42	1.39	1.42	2.14	0.20	–	–
Total Assets	239	254	254	275	502	294	519	405	359	343	346	314	291	278	206	–	–
Accounts Payable	8.22	16	22	13	12	52	54	35	25	31	35	32	32	23	17	–	–
Accrued Expenses	22	23	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	3.44	0.94	0.58	98	0	12	9.79	4.94	4.94	7.87	8.35	6.06	5.93	7.01	4.33	–	–
Current Debt	3.44	0.94	0.58	98	0	12	9.79	4.94	4.94	7.87	8.35	6.06	5.93	7.01	4.33	–	–
Current Portion of Leases	0.39	3.96	1.15	1.74	3.77	4.30	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	–	1.23	–	–	–	–	–	–
Deferred Revenue (Current)	3.42	2.11	4.10	0.92	0.29	0.35	0.50	2.63	0.31	0.83	0.84	1.25	1.25	0.16	2.66	–	–
Other Current Liabilities	–	–	–	–	–	–	1.74	5.28	8.39	1.74	1.69	2.02	–	–	–	–	–
Total Current Liabilities	30	39	39	177	102	164	137	88	51	56	56	48	51	67	31	–	–
Long-Term Debt	–	101	84	0	165	101	87	37	42	46	34	28	34	40	16	–	–
Long-Term Leases	1.34	1.73	6.50	9.97	20	23	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.73	5.69	7.64	12	24	27	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	0.54	0.38	0.13	5.98	14	19	17	25	22	34	30	24	18	11	–	–
Other Long-Term Liabilities	9.74	12	0.17	0.19	2.87	4.55	1.74	–	–	–	1.69	2.02	1.35	1.11	11	–	–
Total Liabilities	192	200	218	187	300	310	249	152	130	130	126	109	111	126	69	–	–
Total Debt	3.44	102	85	98	165	113	97	42	47	54	43	34	40	47	20	–	–
Common Stock	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	–	–
Additional Paid-In Capital	207	178	174	167	166	163	160	142	142	137	133	131	126	120	119	–	–
Retained Earnings	-205	-167	-179	-79	38	71	110	109	84	73	85	72	52	30	17	–	–
Comprehensive Income & Other	–	–	0	-0.59	-1.36	-2.81	0.06	1.15	0.43	–	–	–	–	–	-0.27	–	–
Shareholders' Equity	1.34	11	-4.23	88	202	230	270	253	227	211	218	203	179	150	136	–	–
Noncontrolling Interest	–	–	–	–	–	–	–	–	1.54	1.62	1.68	1.69	1.72	1.82	1.67	–	–
Total Equity	1.34	11	-4.23	88	202	230	270	253	228	212	220	205	180	152	138	–	–
Total Liabilities & Equity	239	254	254	275	502	541	519	405	359	343	346	314	291	278	206	–	–
Shares Outstanding(shares)	37	31	30	30	29	29	29	28	27	27	27	27	26	26	26	–	–
Allowance for Credit Losses	–	–	–	–	–	0.44	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 31.3%
Operating margin: -13.4%
Net margin: -30.0%
Return on equity, FY2025: -612.1%

Financial strength

Current ratio: 3.87
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 79.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –